R848, a toll-like receptor 7 agonist, inhibits osteoclast differentiation but not survival or bone-resorbing function of mature osteoclasts

By Miyamoto Arei  

Cytotechnology, Vol. 64, Iss. 3, 2012-05 ,pp. : 331-339

Springer Publishing Company

Access to resources Recommend Favorite

Cloning and characterization of the gene encoding mouse osteoclast differentiation factor

By Kodaira K.   Kodaira K.   Mizuno A.   Yasuda H.   Shima N.   Murakami A.   Ueda M.   Higashio K.  

Gene, Vol. 230, Iss. 1, 1999-04 ,pp. : 121-127

Elsevier

Access to resources Recommend Favorite

Stimulation of Osteoclast Differentiation in Vitro by Mouse Oncostatin M, Leukaemia Inhibitory Factor, Cardiotrophin-1 and Interleukin 6: Synergy with Dexamethasone

By Richards C.D.   Langdon C.   deschamps P.   Pennica D.   Shaughnessy S.G.  

Cytokine, Vol. 12, Iss. 6, 2000-06 ,pp. : 613-621

Academic Press

Access to resources Recommend Favorite

Role of the P2X7 receptor in the osteogenic differentiation of mesenchymal cells and in osteoclast fusion: Presented by: Maria P. Abbracchio

By Wang Ning   Gartland Alison  

Purinergic Signalling, Vol. 9, Iss. 3, 2013-09 ,pp. : 281-284

Springer Publishing Company

Access to resources Recommend Favorite

Association of sustained ERK activity with integrin 3 induction during receptor activator of nuclear factor kappaB ligand (RANKL)-directed osteoclast differentiation

By Kim H.-H.   Chung W.J.   Lee S.W.   Chung P.-J.   You J.W.   Kwon H.J.   Tanaka S.   Lee Z.H.  

Experimental Cell Research, Vol. 289, Iss. 2, 2003-10 ,pp. : 368-377

Elsevier

Access to resources Recommend Favorite